These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1196613)

  • 1. [Study of the metabolic effect of miscleron (clofibrate) in animal experiments].
    Krámer M; Bedö M; Blaskovits A; Gefferth G; Tarján R
    Orv Hetil; 1975 Nov; 116(47):2774-8. PubMed ID: 1196613
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic effects of clofibrate on experimental animals.
    Bedö M; Kramer M; Blaskovits A; Gefferth G; Tarjan R
    Arzneimittelforschung; 1978; 28(7):1076-80. PubMed ID: 582692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
    Virág S; Dénes R; Pozsonyi T; Tury K
    Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of ethanol and clofibrate on the activity of lipid catabolism enzyme systems in rat liver].
    Antonenko VD; Popova SV; Panchenko LF
    Farmakol Toksikol; 1983; 46(5):86-90. PubMed ID: 6138280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofibrate hypocholesterolemia associated with increased hepatic copper.
    Klevay LM
    Drug Nutr Interact; 1983; 2(2):131-7. PubMed ID: 6678750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
    Adameová A; Kuzelová M; Faberová V; Svec P
    Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvement in the functional and morphological mononuclear blood cell indices under the influence of miscleron].
    Nemirovskiĭ VS; Ostroumova MN; Blagosklonnaia IaV; Uskova AL; Freĭdlin IS
    Vopr Onkol; 1978; 24(4):65-8. PubMed ID: 654176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
    Marmo E; Caputi AP; Vacca C; Imperatore A; Cataldi S
    Clin Ter; 1974 Mar; 68(6):519-67. PubMed ID: 4831379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clofibrate and phosphate metabolism].
    Michailov ML
    Cor Vasa; 1984; 26(4):309-16. PubMed ID: 6488804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and biochemical aspects of clofibrate].
    Ylikahri R; Kähönen M
    Duodecim; 1972; 88(10):688-99. PubMed ID: 5068884
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Miscleron (clofibrate) on the labelled lipoprotein uptake of the aorta in normal and cholesterol pretreated rabbits.
    Virág S; Dénes R; Pozsonyi T; Tury K
    Ther Hung; 1972; 20(1):62-4. PubMed ID: 4341573
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carbohydrates and lipids in the blood serum and liver of rats during recovery from 15-hour hypokinesia].
    Potapov PP; Tikhomirova NA
    Kosm Biol Aviakosm Med; 1984; 18(5):87-8. PubMed ID: 6513478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.